Showing 282 results for "chronic thromboembolic pulmonary hypertension"

Balloon angioplasty could be effective CTEPH treatment option

Pulmonary endarterectomy (PEA) and balloon pulmonary angioplasty (BPA) — two treatment approaches for chronic thromboembolic pulmonary hypertension (CTEPH) — significantly improved blood flow dynamics and functional capacity in patients given either procedure, a study from Norway reported. PEA was more effective at reducing pressure and resistance in the lungs’…

Apelin-17 levels may be used for IPAH diagnosis, study shows

A peptide called apelin-17 may be used as a diagnostic biomarker for idiopathic pulmonary arterial hypertension (IPAH), according to the results of a new study. Apelin-17 levels were found to detect IPAH with an accuracy similar to NT-proBNP and GDF-15 — two established biomarkers for pulmonary hypertension (PH)…

PAH Places Great Burden on Patients, Healthcare in Sweden

Pulmonary arterial hypertension (PAH) is associated with high utilization of healthcare resources by patients and with productivity loss, starting years before diagnosis, according to a study in Sweden. “The economic and clinical burden associated with PAH suggests that strategies for earlier diagnosis and more effective treatments are warranted,” researchers…

Unhealthy Behaviors, Thoughts Can Cause Depression or Anxiety

Unhealthy changes in cognition, like a focus on worries, can lead to anxiety in people with pulmonary hypertension(PH), while those in behavior, like social avoidance, may cause depression, according to a U.K. study. Greater dyspnea, or shortness of breath, was also a contributing factor when paired with these cognitive or…

30 Days of PH: A PH Specialist Pays Tribute to His Patients

Dr. Sahay is a PH specialist based in Houston, Texas. (Photo courtesy of Dr. Sandeep Sahay) Day 20 of 30 This is Dr. Sandeep Sahay’s story: My name is Dr. Sahay, and I’m the co-director of the Pulmonary Hypertension Comprehensive Care and Chronic Thromboembolic Pulmonary Hypertension Programs, and associate…

30 Days of PH: My Long and Terrifying Journey to Diagnosis

For Lindsay Moretz, it was a long struggle to finally reach an accurate diagnosis. (Photo courtesy of Lindsay Moretz) Day 7 of 30 This is Lindsay Moretz’s story: I could write a book about the period of my life from my pulmonary hypertension (PH) diagnosis to where I’m…

Interactive Calendar of Resources, More to Mark PH Awareness Month

Patients, caregivers, family members, and friends are set to mark Pulmonary Hypertension Awareness Month, observed each November to call attention to the complex, chronic, progressive disorder. Awareness and education are vital to heightening the recognition, diagnosis, understanding, and management of pulmonary hypertension (PH), a disease associated with high blood…

Study: Ang-2 Blood Test May Predict Treatment Outcomes in CTEPH

A blood test for angiopoietin-2 (Ang-2), a protein associated with forming new blood vessels, may predict treatment outcomes in people with chronic thromboembolic pulmonary hypertension (CTEPH), a study showed. Researchers found that the protein’s level was significantly higher in the bloodstream of patients with this rare form of…

What Do a Jet Fighter and a PAH Fighter Have in Common?

Answer: resilience. Randolph Reynolds is geared up and ready to fly an F-105 in 1978. (Courtesy of Randolph Reynolds) Randolph Reynolds, 81, had an amazing career as a jet fighter and instructor pilot in the United States Air Force, flying magnificent aircraft like the F-105 Thunderchief and F-4D Phantom…

Tissue Oxygenation Measure Predicts PH Outcomes: Study

Mixed venous oxygen tension (PvO2) — a measure for tissue oxygenation — is a significant predictor of outcomes in pulmonary hypertension (PH), a study suggested. Specifically, lower PvO2 was significantly associated with poor outcomes in people with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH),…